SK bioscience Launches Global Clinical Trials for mRNA Vaccine Against Japanese Encephalitis SK bioscience has initiated Phase 1/2 clinical trials of its mRNA vaccine for Japanese encephalitis, aiming for rapid pandemic response and global accessibility.

SK bioscience Launches Global Clinical Trials for mRNA Vaccine Against Japanese Encephalitis #South_Korea #Seongnam #SK_bioscience #mRNA_Vaccine #Japanese_Encephalitis

SK bioscience Launches mRNA Vaccine Trials for Japanese Encephalitis, Aiming for Global Impact SK bioscience has received approval for clinical trials of its mRNA vaccine candidate against Japanese encephalitis, aiming for swift global response.

SK bioscience Launches mRNA Vaccine Trials for Japanese Encephalitis, Aiming for Global Impact #South_Korea #Seongnam #SK_bioscience #mRNA_Vaccine #Japanese_Encephalitis